Top Companies in Neuroscience

Neuroscience is a study of that is concerned with the structure and function of the nervous system. The study covers the evolution, development, physiology, cellular & molecular biology, anatomy & pharmacology of the nervous system, and also behavioral, computational and cognitive neuroscience. Tools such as MRI scans and computerized 3-D models are used to perform tests for some common conditions including Down syndrome, Parkinson's disease, brain tumors, effects of stroke such as, language loss and many others.

Increasing cases of neurological disorders, which include Alzheimer’s, Parkinson’s diseases, and other dementias are expected to boost the neuroscience market growth over the forecast period. For instance, according to according to the World Alzheimer Report 2015 published by Alzheimer’s Disease International (ADI), in 2015 the new dementia cases in the regions were 4.9 million (49.0%) in Asia, 2.5 million (25.0%) in Europe, 1.7 million (18.0%) in the Americas, and 0.8 million (8.0%) in Africa. Furthermore, according to the Parkinson's UK, in 2015 there were around 137,000 people suffered from Parkinson’s in the U.K.

Click Here To Download PDF Copy

Top Companies operating in this research are:

Ø  General Electric Company

Ø  Siemens AG

Ø  Mediso Ltd.

Ø  Laserglow Technologies

Ø  Mightex Systems

Ø  Prizmatix

Ø  Noldus Information Technology

Ø  NeuroNexus

Ø  Scientifica

Ø  Femtonics

Key Trend:

The rising trade of neuroscience consumables and devices for the diagnostics and imaging purpose of nervous system and brain is projected to encourage the growth of the global neuroscience market in the next few years. The function and structure of the nervous system and neurological disorders in several countries such as Russia and Poland is likely to enhance the growth of the overall market in the coming few years. Moreover, the rising awareness among consumers regarding to the benefits of advanced neuroscience devices, including combination of other imaging devices is projected to accelerate the growth of the global neuroscience market in the next few years.

Parkinson’s disease is the second most common age-related neurodegenerative disorder after Alzheimer’s disease. For instance, according to the Parkinson's UK, in 2015, estimated number of people suffering with the Parkinson’s disease in Northern Ireland were 241, amongst which 157 were male and 85 were female. 

North America is expected to contribute to the largest share in the neuroscience market in the coming years, due to rising focus on the development of new products and the rising awareness regarding to the benefits of advanced neuroscience devices in the region. However, Asia Pacific is expected to witness significant growth in the market during the forecast period, owing to growing government spending on the healthcare infrastructure and rising spending on the research and development activities in the region.